The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Benefit of whole-pelvis radiation for patients with muscle-invasive bladder cancer: An inverse probability treatment-weighted analysis.
 
Ronald Kool
Consulting or Advisory Role - Janssen Oncology
Travel, Accommodations, Expenses - Janssen Oncology; Zodiac Pharma
 
Gautier Marcq
No Relationships to Disclose
 
Alice Dragomir
No Relationships to Disclose
 
Girish S. Kulkarni
Honoraria - Abbvie; AstraZeneca Canada; Bayer; BioSyent; Knight Pharmaceuticals; Tersera
Consulting or Advisory Role - Bristol-Myers Squibb; EMD Serono; Ferring; Janssen Oncology; Merck; Theralase; Verity Pharmaceuticals
 
Rodney H. Breau
No Relationships to Disclose
 
Micheal Kim
No Relationships to Disclose
 
Ionut Busca
No Relationships to Disclose
 
Hamidreza Abdi
No Relationships to Disclose
 
Mark Dawidek
No Relationships to Disclose
 
Michael Uy
No Relationships to Disclose
 
Gagan Fervaha
No Relationships to Disclose
 
Nimira S. Alimohamed
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; EMD Serono; Merck; Pfizer; Seagen
 
Jonathan Izawa
No Relationships to Disclose
 
Claudio Jeldres
No Relationships to Disclose
 
Ricardo A. Rendon
Stock and Other Ownership Interests - Myovant Sciences
Honoraria - Astellas Pharma; Bayer; Janssen; Sanofi
Speakers' Bureau - Astellas Pharma; Bayer; Janssen
 
Bobby Shayegan
Consulting or Advisory Role - Abbvie; Astellas Pharma; Bayer; Janssen Oncology; Knight Pharmaceuticals; Novartis Canada Pharmaceuticals Inc; Novartis Canada Pharmaceuticals Inc; Tersera; Tolmar
 
D. Robert Siemens
No Relationships to Disclose
 
Peter C. Black
Consulting or Advisory Role - Abbvie; Astellas Pharma; AstraZeneca; Bayer; Biosyent; Bristol-Myers Squibb; EMD Serono; Ferring; Janssen Oncology; Merck; Minogue Medical; miR Scientific; Nonagen Bioscience; Pfizer; Prokarium; Protara Therapeutics; Protara Therapeutics; QED Therapeutics; Roche Canada; Sanofi; Sesen Bio; STIMIT; TerSera; Tolmar; Urogen pharma; Verity Pharmaceuticals
Speakers' Bureau - Bayer; BioSyent; Pfizer; TerSera
Research Funding - iProgen
Patents, Royalties, Other Intellectual Property - 1. PCT/CA2014/000787. Canada. 2014-11-03 Cancer Biomarkers and Classifiers and uses thereof. 2. #61899648 United States. 2013-03-13 Bladder cancer signature.
 
Fabio L. Cury
No Relationships to Disclose
 
Wassim Kassouf
Consulting or Advisory Role - BMS; Ferring; Janssen; Merck; Roche; Sesen Bio
Research Funding - Roche (Inst); Sesen Bio (Inst)